Reports

Now in its thirteenth edition — Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the global POC diagnostics market with updated insights and forecasts through 2030.

Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 13th Edition delivers a comprehensive, forward-looking evaluation of one of the most strategically important segments of the in vitro diagnostics (IVD) industry.…

Report Description

How loyal are researchers to their antibody suppliers, and what drives them to switch? Which catalog antibody providers lead in customer satisfaction and retention, and where do gaps exist?

The 2026 edition of Customer Loyalty and Switching: Antibodies delivers a definitive read on where life science professionals stand today. Drawing on responses from…

The SDi Global Assessment Report provides detailed data on every major life science and analytical instrument technology in the industry, enabling you and your staff to make accurate evaluations and informed decisions. Numerous vendors, distributors and investors will reference this report over the coming years as the most comprehensive and accurate source of information on…

The global in vitro diagnostics (IVD) market is entering a period of measured but positive growth, shaped less by disruptive platform launches and more by strategic portfolio realignment, digital integration, and selective innovation. Kalorama Information’s 19th Edition of The Worldwide Market for In Vitro Diagnostic (IVD) Tests examines how industry participants are navigating competitive pressures, cost constraints,…

The in vitro diagnostics (IVD) industry is a cornerstone of modern healthcare, empowering clinicians to detect disease, monitor health conditions, and guide treatment decisions with precision. As healthcare continues to evolve—driven by rising rates of chronic conditions such as diabetes and cardiovascular disease, along with ongoing and emerging infectious threats—the IVD market is…

IMV’s 2026 Nuclear Medicine Market Outlook examines nuclear medicine procedure volumes, purchase plans, and buying criteria for future nuclear medicine purchases. Learn how NM administrators feel about their department’s future outlook and how they prioritize their goals in light of industry challenges. The report explores nuclear medicine market trends, including NM procedure volume, installed base…

Immunoassays remain a foundational pillar of the in vitro diagnostics (IVD) landscape, underpinning a broad range of clinical testing applications despite the maturity of many platforms. Their continued relevance reflects both their versatility across disease areas and the steady pace of technological refinement that has sustained growth and clinical adoption over time. This Kalorama Information…

How has AI reshaped life science workflows in the past year? Which AI solutions have emerged as indispensable to researchers and which have fallen short? Do scientists genuinely trust AI-generated results, and how are those perceptions shifting? 

 

The 2026 edition of Perceptions of Artificial Intelligence in the Life Sciences delivers a definitive read on where life science professionals…

The Kalorama Molecular Diagnostics Quarterly Datastream is exclusively available to purchasers of our annual reports: Worldwide In Vitro Diagnostic (IVD) Tests, World Market for Molecular Diagnostics, or Molecular Point-of-Care (mPOC). This quarterly update covers markets detailed in these reports.

PET imaging has grown over the past two decades to become a mainstay in the diagnosis and management of cancer patients. While oncology scans continue to comprise the majority of PET scans, new radiopharmaceuticals offer the promise of increasing the efficacy of PET imaging for cardiology and neurology.

IMV’s 2026 PET Imaging Outlook Summary Report…

The global market for respiratory and non-respiratory IVD panel-based testing is undergoing continued structural evolution. Panel-based tests allow for the simultaneous detection of multiple pathogens and or resistance markers from a single specimen, supporting efficient workflows, faster time to results, and greater diagnostic confidence. Market growth is increasingly driven by broader clinical adoption and expanding…

Molecular point-of-care testing continues to reshape diagnostic workflows by bringing the accuracy of molecular methods closer to the patient. In Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 11th Edition (2025 to 2030), Kalorama Information examines a market that has matured significantly over the past decade while remaining dynamic. Distinctions between true point-of-care and near patient…